Home
Market Capitalization of Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd
NSE: GUJTHEMIS
Market Cap
Key Highlights
- The Market Cap of Gujarat Themis Biosyn Ltd is ₹ 2663 crore as of 21 Feb 25 .
- The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 244.4 as of 21 Feb 15:30 .
- The Dividend Payouts of Gujarat Themis Biosyn Ltd changed from ₹ 2 on Nov 24, 2021 to ₹ 0.25 on Jul 15, 2024 . This represents a CAGR of -29.29% over 6 years.

Gujarat Themis Biosyn Ltd
NSE: GUJTHEMIS
Share Price
Market Price of Gujarat Themis Biosyn Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 244.4 |
20 Feb 2025 | 244.45 |
19 Feb 2025 | 251.5 |
18 Feb 2025 | 212.2 |
17 Feb 2025 | 229.75 |
14 Feb 2025 | 249.15 |
13 Feb 2025 | 260.5 |
12 Feb 2025 | 263.7 |
11 Feb 2025 | 263 |
10 Feb 2025 | 274.35 |
SWOT Analysis Of Gujarat Themis Biosyn Ltd
BlinkX Score for Gujarat Themis Biosyn Ltd
Asset Value vs Market Value of Gujarat Themis Biosyn Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Gujarat Themis Biosyn Ltd
Historical P/E Ratio of Gujarat Themis Biosyn Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Gujarat Themis Biosyn Ltd
Historical Revenue of Gujarat Themis Biosyn Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Gujarat Themis Biosyn Ltd
Historical EBITDA of Gujarat Themis Biosyn Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Gujarat Themis Biosyn Ltd
Historical Net Profit of Gujarat Themis Biosyn Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Gujarat Themis Biosyn Ltd
Historical Dividend Payouts of Gujarat Themis Biosyn Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Gujarat Themis Biosyn Ltd
About Gujarat Themis Biosyn Ltd
- Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
- It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.
Gujarat Themis Biosyn Ltd News Hub
Gujarat Themis Biosyn standalone net profit declines 15.71% in the September 2024 quarter
Net profit of Gujarat Themis Biosyn declined 15.71% to Rs 10.57 crore in the quarter ended September
Read more
25 Oct 24
Gujarat Themis Biosyn schedules board meeting
Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 October 202
Read more
19 Oct 24
Board approved merger of Gujarat Themis Biosyn with Themis Medicare
The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have approved a Sch
Read more
19 Nov 24
Gujarat Themis Biosyn standalone net profit declines 0.31% in the December 2024 quarter
Net profit of Gujarat Themis Biosyn declined 0.31% to Rs 12.97 crore in the quarter ended December 2
Read more
14 Feb 25